<?xml version="1.0" encoding="UTF-8"?>
<p id="Par9">As many as 65% of COVID-19 affected individuals reported hyposmia and ageusia
 <sup>
  <xref ref-type="bibr" rid="CR43">43</xref>
 </sup>, features that suggest the possibility of trans-synaptic spread via the olfactory, lingual, and glossopharyngeal nerves (Fig. 
 <xref rid="Fig1" ref-type="fig">1</xref>), secondary to a respiratory route of infection. Hyposmia is now officially recognized as a symptom of COVID-19 by the UK government and may be a sign in “asymptomatic” carriers who may not have upper respiratory tract symptoms.
</p>
